Highlights
The global Intra-Uterine Contraceptive Devices market was valued at US$ 2064.7 million in 2022 and is anticipated to reach US$ 2418.5 million by 2029, witnessing a CAGR of 2.3% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Intra-Uterine Contraceptive Devices is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Intra-Uterine Contraceptive Devices is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Intra-Uterine Contraceptive Devices include Bayer AG, Teva Pharmaceuticals Industries, Mona Lisa N.V., DKT International, Egemen International, Melbea AG, Ocon Medical Ltd., Pregna International Limited and Medical Engineering Corporation SA, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Intra-Uterine Contraceptive Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intra-Uterine Contraceptive Devices.
The Intra-Uterine Contraceptive Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Intra-Uterine Contraceptive Devices market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intra-Uterine Contraceptive Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Bayer AG
Teva Pharmaceuticals Industries
Mona Lisa N.V.
DKT International
Egemen International
Melbea AG
Ocon Medical Ltd.
Pregna International Limited
Medical Engineering Corporation SA
SMB Corporation and Meril Life Sciences Pvt. Ltd.
Medu Scientific Ltd, China RH Contraceptives Co., Ltd
Sanghai Jolly Medical Education Co., Ltd
Bernstein Leibhard LLP
Zheijang Daji Medical Instruments, Ltd.
Nimble International
AME Line, Technico
Cepeo
Contraceptivos
Injeflex Ind And Com Ltda
Bersil
Amed
Segment by Type
Copper IUCD
Hormonal IUCD
Segment by Application
Hospitals
Gynaecology Clinics
Community Healthcare
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Intra-Uterine Contraceptive Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Intra-Uterine Contraceptive Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Intra-Uterine Contraceptive Devices 麻豆原创 Overview
1.1 Product Overview and Scope of Intra-Uterine Contraceptive Devices
1.2 Intra-Uterine Contraceptive Devices Segment by Type
1.2.1 Global Intra-Uterine Contraceptive Devices 麻豆原创 Value Comparison by Type (2023-2029)
1.2.2 Copper IUCD
1.2.3 Hormonal IUCD
1.3 Intra-Uterine Contraceptive Devices Segment by Application
1.3.1 Global Intra-Uterine Contraceptive Devices 麻豆原创 Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Gynaecology Clinics
1.3.4 Community Healthcare
1.4 Global Intra-Uterine Contraceptive Devices 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Intra-Uterine Contraceptive Devices Revenue 2018-2029
1.4.2 Global Intra-Uterine Contraceptive Devices Sales 2018-2029
1.4.3 Global Intra-Uterine Contraceptive Devices 麻豆原创 Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Intra-Uterine Contraceptive Devices 麻豆原创 Competition by Manufacturers
2.1 Global Intra-Uterine Contraceptive Devices Sales 麻豆原创 Share by Manufacturers (2018-2023)
2.2 Global Intra-Uterine Contraceptive Devices Revenue 麻豆原创 Share by Manufacturers (2018-2023)
2.3 Global Intra-Uterine Contraceptive Devices Average Price by Manufacturers (2018-2023)
2.4 Global Intra-Uterine Contraceptive Devices Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Intra-Uterine Contraceptive Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Intra-Uterine Contraceptive Devices, Product Type & Application
2.7 Intra-Uterine Contraceptive Devices 麻豆原创 Competitive Situation and Trends
2.7.1 Intra-Uterine Contraceptive Devices 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Intra-Uterine Contraceptive Devices Players 麻豆原创 Share by Revenue
2.7.3 Global Intra-Uterine Contraceptive Devices 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Intra-Uterine Contraceptive Devices Retrospective 麻豆原创 Scenario by Region
3.1 Global Intra-Uterine Contraceptive Devices 麻豆原创 Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Intra-Uterine Contraceptive Devices Global Intra-Uterine Contraceptive Devices Sales by Region: 2018-2029
3.2.1 Global Intra-Uterine Contraceptive Devices Sales by Region: 2018-2023
3.2.2 Global Intra-Uterine Contraceptive Devices Sales by Region: 2024-2029
3.3 Global Intra-Uterine Contraceptive Devices Global Intra-Uterine Contraceptive Devices Revenue by Region: 2018-2029
3.3.1 Global Intra-Uterine Contraceptive Devices Revenue by Region: 2018-2023
3.3.2 Global Intra-Uterine Contraceptive Devices Revenue by Region: 2024-2029
3.4 North America Intra-Uterine Contraceptive Devices 麻豆原创 Facts & Figures by Country
3.4.1 North America Intra-Uterine Contraceptive Devices 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Intra-Uterine Contraceptive Devices Sales by Country (2018-2029)
3.4.3 North America Intra-Uterine Contraceptive Devices Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Intra-Uterine Contraceptive Devices 麻豆原创 Facts & Figures by Country
3.5.1 Europe Intra-Uterine Contraceptive Devices 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Intra-Uterine Contraceptive Devices Sales by Country (2018-2029)
3.5.3 Europe Intra-Uterine Contraceptive Devices Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Intra-Uterine Contraceptive Devices 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Intra-Uterine Contraceptive Devices 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Intra-Uterine Contraceptive Devices Sales by Country (2018-2029)
3.6.3 Asia Pacific Intra-Uterine Contraceptive Devices Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Intra-Uterine Contraceptive Devices 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Intra-Uterine Contraceptive Devices 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Intra-Uterine Contraceptive Devices Sales by Country (2018-2029)
3.7.3 Latin America Intra-Uterine Contraceptive Devices Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Intra-Uterine Contraceptive Devices 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Intra-Uterine Contraceptive Devices 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Intra-Uterine Contraceptive Devices Sales by Country (2018-2029)
3.8.3 Middle East and Africa Intra-Uterine Contraceptive Devices Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Intra-Uterine Contraceptive Devices Sales by Type (2018-2029)
4.1.1 Global Intra-Uterine Contraceptive Devices Sales by Type (2018-2023)
4.1.2 Global Intra-Uterine Contraceptive Devices Sales by Type (2024-2029)
4.1.3 Global Intra-Uterine Contraceptive Devices Sales 麻豆原创 Share by Type (2018-2029)
4.2 Global Intra-Uterine Contraceptive Devices Revenue by Type (2018-2029)
4.2.1 Global Intra-Uterine Contraceptive Devices Revenue by Type (2018-2023)
4.2.2 Global Intra-Uterine Contraceptive Devices Revenue by Type (2024-2029)
4.2.3 Global Intra-Uterine Contraceptive Devices Revenue 麻豆原创 Share by Type (2018-2029)
4.3 Global Intra-Uterine Contraceptive Devices Price by Type (2018-2029)
5 Segment by Application
5.1 Global Intra-Uterine Contraceptive Devices Sales by Application (2018-2029)
5.1.1 Global Intra-Uterine Contraceptive Devices Sales by Application (2018-2023)
5.1.2 Global Intra-Uterine Contraceptive Devices Sales by Application (2024-2029)
5.1.3 Global Intra-Uterine Contraceptive Devices Sales 麻豆原创 Share by Application (2018-2029)
5.2 Global Intra-Uterine Contraceptive Devices Revenue by Application (2018-2029)
5.2.1 Global Intra-Uterine Contraceptive Devices Revenue by Application (2018-2023)
5.2.2 Global Intra-Uterine Contraceptive Devices Revenue by Application (2024-2029)
5.2.3 Global Intra-Uterine Contraceptive Devices Revenue 麻豆原创 Share by Application (2018-2029)
5.3 Global Intra-Uterine Contraceptive Devices Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Bayer AG
6.1.1 Bayer AG Corporation Information
6.1.2 Bayer AG Description and Business Overview
6.1.3 Bayer AG Intra-Uterine Contraceptive Devices Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Bayer AG Intra-Uterine Contraceptive Devices Product Portfolio
6.1.5 Bayer AG Recent Developments/Updates
6.2 Teva Pharmaceuticals Industries
6.2.1 Teva Pharmaceuticals Industries Corporation Information
6.2.2 Teva Pharmaceuticals Industries Description and Business Overview
6.2.3 Teva Pharmaceuticals Industries Intra-Uterine Contraceptive Devices Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Teva Pharmaceuticals Industries Intra-Uterine Contraceptive Devices Product Portfolio
6.2.5 Teva Pharmaceuticals Industries Recent Developments/Updates
6.3 Mona Lisa N.V.
6.3.1 Mona Lisa N.V. Corporation Information
6.3.2 Mona Lisa N.V. Description and Business Overview
6.3.3 Mona Lisa N.V. Intra-Uterine Contraceptive Devices Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Mona Lisa N.V. Intra-Uterine Contraceptive Devices Product Portfolio
6.3.5 Mona Lisa N.V. Recent Developments/Updates
6.4 DKT International
6.4.1 DKT International Corporation Information
6.4.2 DKT International Description and Business Overview
6.4.3 DKT International Intra-Uterine Contraceptive Devices Sales, Revenue and Gross Margin (2018-2023)
6.4.4 DKT International Intra-Uterine Contraceptive Devices Product Portfolio
6.4.5 DKT International Recent Developments/Updates
6.5 Egemen International
6.5.1 Egemen International Corporation Information
6.5.2 Egemen International Description and Business Overview
6.5.3 Egemen International Intra-Uterine Contraceptive Devices Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Egemen International Intra-Uterine Contraceptive Devices Product Portfolio
6.5.5 Egemen International Recent Developments/Updates
6.6 Melbea AG
6.6.1 Melbea AG Corporation Information
6.6.2 Melbea AG Description and Business Overview
6.6.3 Melbea AG Intra-Uterine Contraceptive Devices Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Melbea AG Intra-Uterine Contraceptive Devices Product Portfolio
6.6.5 Melbea AG Recent Developments/Updates
6.7 Ocon Medical Ltd.
6.6.1 Ocon Medical Ltd. Corporation Information
6.6.2 Ocon Medical Ltd. Description and Business Overview
6.6.3 Ocon Medical Ltd. Intra-Uterine Contraceptive Devices Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Ocon Medical Ltd. Intra-Uterine Contraceptive Devices Product Portfolio
6.7.5 Ocon Medical Ltd. Recent Developments/Updates
6.8 Pregna International Limited
6.8.1 Pregna International Limited Corporation Information
6.8.2 Pregna International Limited Description and Business Overview
6.8.3 Pregna International Limited Intra-Uterine Contraceptive Devices Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Pregna International Limited Intra-Uterine Contraceptive Devices Product Portfolio
6.8.5 Pregna International Limited Recent Developments/Updates
6.9 Medical Engineering Corporation SA
6.9.1 Medical Engineering Corporation SA Corporation Information
6.9.2 Medical Engineering Corporation SA Description and Business Overview
6.9.3 Medical Engineering Corporation SA Intra-Uterine Contraceptive Devices Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Medical Engineering Corporation SA Intra-Uterine Contraceptive Devices Product Portfolio
6.9.5 Medical Engineering Corporation SA Recent Developments/Updates
6.10 SMB Corporation and Meril Life Sciences Pvt. Ltd.
6.10.1 SMB Corporation and Meril Life Sciences Pvt. Ltd. Corporation Information
6.10.2 SMB Corporation and Meril Life Sciences Pvt. Ltd. Description and Business Overview
6.10.3 SMB Corporation and Meril Life Sciences Pvt. Ltd. Intra-Uterine Contraceptive Devices Sales, Revenue and Gross Margin (2018-2023)
6.10.4 SMB Corporation and Meril Life Sciences Pvt. Ltd. Intra-Uterine Contraceptive Devices Product Portfolio
6.10.5 SMB Corporation and Meril Life Sciences Pvt. Ltd. Recent Developments/Updates
6.11 Medu Scientific Ltd, China RH Contraceptives Co., Ltd
6.11.1 Medu Scientific Ltd, China RH Contraceptives Co., Ltd Corporation Information
6.11.2 Medu Scientific Ltd, China RH Contraceptives Co., Ltd Intra-Uterine Contraceptive Devices Description and Business Overview
6.11.3 Medu Scientific Ltd, China RH Contraceptives Co., Ltd Intra-Uterine Contraceptive Devices Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Medu Scientific Ltd, China RH Contraceptives Co., Ltd Intra-Uterine Contraceptive Devices Product Portfolio
6.11.5 Medu Scientific Ltd, China RH Contraceptives Co., Ltd Recent Developments/Updates
6.12 Sanghai Jolly Medical Education Co., Ltd
6.12.1 Sanghai Jolly Medical Education Co., Ltd Corporation Information
6.12.2 Sanghai Jolly Medical Education Co., Ltd Intra-Uterine Contraceptive Devices Description and Business Overview
6.12.3 Sanghai Jolly Medical Education Co., Ltd Intra-Uterine Contraceptive Devices Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Sanghai Jolly Medical Education Co., Ltd Intra-Uterine Contraceptive Devices Product Portfolio
6.12.5 Sanghai Jolly Medical Education Co., Ltd Recent Developments/Updates
6.13 Bernstein Leibhard LLP
6.13.1 Bernstein Leibhard LLP Corporation Information
6.13.2 Bernstein Leibhard LLP Intra-Uterine Contraceptive Devices Description and Business Overview
6.13.3 Bernstein Leibhard LLP Intra-Uterine Contraceptive Devices Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Bernstein Leibhard LLP Intra-Uterine Contraceptive Devices Product Portfolio
6.13.5 Bernstein Leibhard LLP Recent Developments/Updates
6.14 Zheijang Daji Medical Instruments, Ltd.
6.14.1 Zheijang Daji Medical Instruments, Ltd. Corporation Information
6.14.2 Zheijang Daji Medical Instruments, Ltd. Intra-Uterine Contraceptive Devices Description and Business Overview
6.14.3 Zheijang Daji Medical Instruments, Ltd. Intra-Uterine Contraceptive Devices Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Zheijang Daji Medical Instruments, Ltd. Intra-Uterine Contraceptive Devices Product Portfolio
6.14.5 Zheijang Daji Medical Instruments, Ltd. Recent Developments/Updates
6.15 Nimble International
6.15.1 Nimble International Corporation Information
6.15.2 Nimble International Intra-Uterine Contraceptive Devices Description and Business Overview
6.15.3 Nimble International Intra-Uterine Contraceptive Devices Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Nimble International Intra-Uterine Contraceptive Devices Product Portfolio
6.15.5 Nimble International Recent Developments/Updates
6.16 AME Line, Technico
6.16.1 AME Line, Technico Corporation Information
6.16.2 AME Line, Technico Intra-Uterine Contraceptive Devices Description and Business Overview
6.16.3 AME Line, Technico Intra-Uterine Contraceptive Devices Sales, Revenue and Gross Margin (2018-2023)
6.16.4 AME Line, Technico Intra-Uterine Contraceptive Devices Product Portfolio
6.16.5 AME Line, Technico Recent Developments/Updates
6.17 Cepeo
6.17.1 Cepeo Corporation Information
6.17.2 Cepeo Intra-Uterine Contraceptive Devices Description and Business Overview
6.17.3 Cepeo Intra-Uterine Contraceptive Devices Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Cepeo Intra-Uterine Contraceptive Devices Product Portfolio
6.17.5 Cepeo Recent Developments/Updates
6.18 Contraceptivos
6.18.1 Contraceptivos Corporation Information
6.18.2 Contraceptivos Intra-Uterine Contraceptive Devices Description and Business Overview
6.18.3 Contraceptivos Intra-Uterine Contraceptive Devices Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Contraceptivos Intra-Uterine Contraceptive Devices Product Portfolio
6.18.5 Contraceptivos Recent Developments/Updates
6.19 Injeflex Ind And Com Ltda
6.19.1 Injeflex Ind And Com Ltda Corporation Information
6.19.2 Injeflex Ind And Com Ltda Intra-Uterine Contraceptive Devices Description and Business Overview
6.19.3 Injeflex Ind And Com Ltda Intra-Uterine Contraceptive Devices Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Injeflex Ind And Com Ltda Intra-Uterine Contraceptive Devices Product Portfolio
6.19.5 Injeflex Ind And Com Ltda Recent Developments/Updates
6.20 Bersil
6.20.1 Bersil Corporation Information
6.20.2 Bersil Intra-Uterine Contraceptive Devices Description and Business Overview
6.20.3 Bersil Intra-Uterine Contraceptive Devices Sales, Revenue and Gross Margin (2018-2023)
6.20.4 Bersil Intra-Uterine Contraceptive Devices Product Portfolio
6.20.5 Bersil Recent Developments/Updates
6.21 Amed
6.21.1 Amed Corporation Information
6.21.2 Amed Intra-Uterine Contraceptive Devices Description and Business Overview
6.21.3 Amed Intra-Uterine Contraceptive Devices Sales, Revenue and Gross Margin (2018-2023)
6.21.4 Amed Intra-Uterine Contraceptive Devices Product Portfolio
6.21.5 Amed Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Intra-Uterine Contraceptive Devices Industry Chain Analysis
7.2 Intra-Uterine Contraceptive Devices Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intra-Uterine Contraceptive Devices Production Mode & Process
7.4 Intra-Uterine Contraceptive Devices Sales and 麻豆原创ing
7.4.1 Intra-Uterine Contraceptive Devices Sales Channels
7.4.2 Intra-Uterine Contraceptive Devices Distributors
7.5 Intra-Uterine Contraceptive Devices Customers
8 Intra-Uterine Contraceptive Devices 麻豆原创 Dynamics
8.1 Intra-Uterine Contraceptive Devices Industry Trends
8.2 Intra-Uterine Contraceptive Devices 麻豆原创 Drivers
8.3 Intra-Uterine Contraceptive Devices 麻豆原创 Challenges
8.4 Intra-Uterine Contraceptive Devices 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Bayer AG
Teva Pharmaceuticals Industries
Mona Lisa N.V.
DKT International
Egemen International
Melbea AG
Ocon Medical Ltd.
Pregna International Limited
Medical Engineering Corporation SA
SMB Corporation and Meril Life Sciences Pvt. Ltd.
Medu Scientific Ltd, China RH Contraceptives Co., Ltd
Sanghai Jolly Medical Education Co., Ltd
Bernstein Leibhard LLP
Zheijang Daji Medical Instruments, Ltd.
Nimble International
AME Line, Technico
Cepeo
Contraceptivos
Injeflex Ind And Com Ltda
Bersil
Amed
听
听
*If Applicable.
